Reducing side effects in advanced cervical cancer treatment
Part of Blood & lymphatic, Cancer, Women’s health & pregnancy clinical trials.
This trial tests a way to reduce blood-related side effects from chemoradiation for locally advanced cervical cancer. It aims to make treatment safer and more tolerable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer that has not spread far, and you are ready to have chemoradiation as a cure.
- You are at least 18 years old. If you are over 70, a special health check is needed.
- Your blood counts (like white cells and platelets) are within healthy ranges before starting treatment.
- You can receive chemotherapy with cisplatin or carboplatin.
- You have not had radiation or immunotherapy for cervical cancer before (some chemo before the trial is okay).
- If you could become pregnant, you must use effective birth control during and for 6 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a radiation plan that is adjusted day by day to better match your cervix and surrounding tissues during treatment. It’s for newly diagnosed, advanced cervical cancer patients who will receive standard pelvic radiation and chemotherapy.
This trial tests a type of radiation that adapts to your body changes during treatment for cervical cancer. It aims to improve accuracy and reduce side effects.
This trial tests a shorter course of radiation combined with chemotherapy and brachytherapy (internal radiation) for cervical cancer that has not spread widely. It aims to make treatment more efficient while still being effective.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This trial tests a combination of pelvic chemoradiation (chemotherapy and radiation) with a special type of brachytherapy (internal radiation) that adjusts the dose during treatment for locally advanced cervical cancer. It aims to improve tumor control while keeping side effects manageable.
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
Hear when a new Cervical Cancer by FIGO Stage 2018 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.